CWP
TMO icon

Cyndeo Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Cyndeo Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$415K Sell
828
-55
-6% -$26.4K 0.02% 377
2026
Q1 		$434K Sell
883
-1,170
-57% -$635K 0.02% 347
2025
Q4 		$1.19M Sell
2,053
-7
-0.3% -$3.96K 0.06% 219
2025
Q3 		$999K Sell
2,060
-2,806
-58% -$1.31M 0.06% 233
2025
Q2 		$1.97M Buy
4,866
+140
+3% +$58.5K 0.12% 161
2025
Q1 		$2.35M Sell
4,726
-1,573
-25% -$852K 0.15% 148
2024
Q4 		$3.28M Buy
6,299
+37
+0.6% +$20.3K 0.22% 118
2024
Q3 		$3.87M Buy
6,262
+1,586
+34% +$939K 0.27% 104
2024
Q2 		$2.59M Buy
4,676
+238
+5% +$136K 0.2% 134
2024
Q1 		$2.58M Sell
4,438
-364
-8% -$204K 0.21% 133
2023
Q4 		$2.55M Buy
4,802
+1,610
+50% +$779K 0.24% 116
2023
Q3 		$1.62M Sell
3,192
-4,943
-61% -$2.63M 0.17% 140
2023
Q2 		$4.24M Buy
8,135
+1,132
+16% +$611K 0.44% 66
2023
Q1 		$4.04M Buy
7,003
+1,100
+19% +$620K 0.44% 70
2022
Q4 		$3.25M Buy
+5,903
New +$3.13M 0.38% 88

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Cyndeo Wealth Partners's TMO Position: Q2 2026 in Review

Cyndeo Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 6.2% in Q2 2026, selling an estimated $26.4K and leaving 828 shares worth $415K. The position accounts for 0.02% of the portfolio, ranked #377.

Cyndeo Wealth Partners first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.24M in Q2 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Cyndeo Wealth Partners held 828 shares of Thermo Fisher Scientific worth $415K as of Q2 2026.
  • Cyndeo Wealth Partners sold 55 Thermo Fisher Scientific shares in Q2 2026, an estimated $26.4K.
  • Thermo Fisher Scientific made up 0.02% of Cyndeo Wealth Partners's portfolio in Q2 2026, its #377 holding.
  • Cyndeo Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Cyndeo Wealth Partners's Thermo Fisher Scientific position peaked at $4.24M in Q2 2023.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Cyndeo Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.